ARCHIVES

PHS Revises Lab Animal Policies

This article is from The Cancer Letter archive.

Vol. 11 No. 19 | May 10, 1985

Download PDF Visit The Full Archive

Related Articles

Vasopermeation Technology Awarded Patent For CA Firm.

September 28, 2001

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

Community Cancer Center Group Formed to Deal With “Toad-Like Pace Of NCI,” Other Problems

June 7, 1974

Andrew von Eschenbach Sworn In As NCI Director.

January 25, 2002

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

FDA Approves Imaging System To Detect Cervical Pre-Cancer

March 31, 2006